Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics
Quinn et al., eBioMedicine, doi:10.1016/j.ebiom.2022.103856
https://c19early.org/quinn.html